← ANALYST RATINGS · TIPRANKS

Stevanato Group (STVN): analyst forecast and price target

$18.90 −1.82% close 16.10.26 · market cap $5.3B · Healthcare · Medical - Instruments & Supplies
Price targets and ratings of

Analyst consensus

Moderate Buy

4 Buy3 Hold0 Sell

Ratings of 7 analysts in the last 3 months

12-month forecast

$23.20+22.8% upside

Based on 7 price targets given in the last 3 months, the average target is $23.20, the highest $26.00, the lowest $20.00. The average is +22.8% from the last price of $18.90.

$15.00$20.00$25.00Jan 26AprJulOctJan 27AprJulOctHigh$26.00Average$23.20Low$20.00
Highest target $26.00 Average target $23.20 Lowest target $20.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Chad Wiatrowski★★★★★★★★★★#8345 · hits 50% · avg +5.7% TD Cowen $25.00 Buy +32.3% Reiterated 14.10.26on TipRanks 09:14 +1.3%next day −0.6%
Justin Bowers★★★★★★★★★★#8679 · hits 47% · avg 0.0% Deutsche Bank $22.00 Hold +16.4% Initiated 07.10.26on TipRanks 07:50 −1.9%next day −0.8% · 5 days +0.3%
Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% Morgan Stanley $20.00 Hold +5.8% Assigned 05.10.26on TipRanks 08:35 −1.4%next day −1.5% · 5 days −4.5%
Name not given — $26.00 Buy +37.6% Reiterated 01.10.26on TipRanks Oct 5 04:05 −4.9%next day +0.4% · 5 days −5.2%
Unknown Analyst UBS $28.00 → $23.00−17.9% Hold +21.7% Initiated 08.09.26on TipRanks Sep 14 09:30 −0.4%next day +0.1% · 5 days +7.1%
Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% Bank of America Securities — Buy — Reiterated 05.08.26on TipRanks 13:25 +2.5%next day +1.1% · 5 days +5.4%
Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% William Blair — Buy — Reiterated 05.08.26on TipRanks 12:26 +2.5%next day +1.1% · 5 days +5.4%
Chad Wiatrowski★★★★★★★★★★#8345 · hits 50% · avg +5.7% TD Cowen $25.00 Buy +32.3% Reiterated 04.08.26on TipRanks Aug 5 02:50 −6.4%next day +2.5% · 5 days +7.2%
Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% Wolfe Research $21.00 Buy +11.1% Initiated 01.06.26on TipRanks 16:45 −0.6%next day −0.7% · 5 days −0.7%
Paul Knight★★★★★★★★★★#4215 · hits 45% · avg +3.5% KeyBanc $37.00 → $32.00−13.5% Buy +69.3% Assigned 05.03.26on TipRanks 02:45 −8.5%next day −1.8% · 5 days −5.7%
David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% Jefferies $23.00 → $17.50−23.9% Hold −7.4% Reiterated 10.02.26on TipRanks 09:20 −5.1%next day +2.4% · 5 days +7.4%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Stevanato Group

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Matt Larew★★★★★★★★★★William Blair · #816
Hits 63%90 of 142 Average return +19.3%
1 year Paul Knight★★★★★★★★★★KeyBanc · #4215
Hits 45%87 of 192 Average return +3.5%
2 years Paul Knight★★★★★★★★★★KeyBanc · #4215
Hits 45%87 of 192 Average return +3.5%

Most profitable

3 months Paul Knight★★★★★★★★★★KeyBanc · #4215
Hits 45%87 of 192 Average return +3.5%
1 year Paul Knight★★★★★★★★★★KeyBanc · #4215
Hits 45%87 of 192 Average return +3.5%
2 years Paul Knight★★★★★★★★★★KeyBanc · #4215
Hits 45%87 of 192 Average return +3.5%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 05.10.26: target $23.50 at a price of $20.20 (+16.3%); now: $23.20 at $18.90 (+22.8%).

$20.00$22.00Sep 15Oct 1Oct 15Top analysts$20.00Average target$23.20Price$18.90

PriceAverage targetTop analysts’ target

Recommendation trend

05101546Oct 2535Nov36Dec135Jan 26116Feb416Mar425Apr433May252Jun172Jul195Aug67Sep59Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy421100
Buy357965
Hold322579
Sell000000

Earnings and sales forecast

Next report: 10.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.18 (from $0.17 to $0.18). Last quarter: $0.16.

Sales

Next quarter’s sales estimate — $360M (from $356M to $367M). Last quarter: $351M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Stevanato Group
  • CEO: Franco Stevanato
  • Employees: 6,010
  • Via Molinella, 17, Piombino Dese, PD, 35017, IT
  • www.stevanatogroup.com

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Data from the stock’s TipRanks forecast page, read 39 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗